Posts Tagged ‘pharmaceutical stocks’

SBIBW has wings, C, ALXA sink

Tuesday, January 18th, 2011

Sterling Bancshares Inc. (Nasdaq: SBIBW) flew 60 percent in price to $3.12. Volume was 101,438, or five times its full-day volume average, amid reports this week that Cullen/Frost Bankers, Inc. may be acquiring the smaller bank.

Citigroup Inc. (NYSE: C) flew off the shelves Tuesday, dealt in 731,126,655 shares Thursday, already surpassing a full-day average of 549,838,000. Prices for C fell 5.5 percent to $4.86. Citigroup reported a $1.3 billion profit, compared with a $7.6 billion loss a year earlier. Revenue jumped to $18.4 billion, from $5.4 billion a year earlier, but fell more than 11% from the third quarter.

Alexza Pharmaceuticals Inc. (Nasdaq: ALXA) fell 19.2 percent in early trading to $1.35. Volume for the stock was 1,784,554 shares, nearly double its all-day average, on word that the company will file a new application for its drug candidate Adusuve Staccato in July.

BNVI gains, MSFT active, CVVT falls hard

Thursday, January 13th, 2011

Bionovo Inc. (Nasdaq: BNVI) shares jumped 34.9 percent to $1.41 Thursday afternoon. Volume was 666,578, or nearly four times its full-day volume average. BNVI is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women’s health and cancer.

Microsoft Inc. (Nasdaq: MSFT) traded in 53,058,639 shares Thursday, just a shade below its daily average of 57,799,300. Prices for the software maker tailed off 1.5 percent to $28.11.

China Valves Technology Inc. (Nasdaq: CVVT) got beaten up 16.3 percent Thursday to $7.30. Volume for the stock was 2,744,317 shares or more than five times its full-day average. CVVT is a leading Chinese metal valve manufacturer, based in Zhengzhou.

CRMD takes wing, NVDA dizzy, RFMI turfs

Wednesday, January 12th, 2011

CorMedix Inc. (AMEX: CRMD) shares gained 20.5% to $2.14 Wednesday. Volume of 157,948 proved nine times its full-day average. CRMD is a pharmaceutical company that seeks to in-license, develop and commercialize therapeutic products for the prevention and treatment of cardiac and renal dysfunction.

NVIDIA Corporation (Nasdaq: NVDA) traded in 57,205,492 shares Wednesday, nearly tripling its daily average. Prices for NVDA leapt 12.5 percent to $22.85. The chip maker’s stock is now up more than 100% over the past three months amid upbeat analyst reviews of its recent initiatives, particularly in the tablet and smart phone markets.

RF Monolithics, Inc. (Nasdaq: RFMI) fell 5.7 percent Wednesday to $1.82 Volume for the stock was 252,129 shares or more than eight times its daily average. Tuesday, the Dallas-based RFMI reported quarterly net income of $160,000 or $0.01 per share.

CRIS incredible, MU moves shares, THOR loses ground

Wednesday, January 12th, 2011

Curis Inc. (Nasdaq: CRIS) shares gained 20.2% to $2.74 Wednesday. Volume of 1,361,514 proved four times its full-day average. The Mass.-based CRIS is a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment.

Micron Technology Inc. (Nasdaq: MU) traded in 53,997,533 shares Wednesday, nearly doubling its daily average of 30,541,700. Prices for MU were up 7.1 to $9.34.

Thoratec Corporatino (Nasdaq: THOR) fell 7.4 percent Wednesday to $28.81. Volume for the stock was 4,263,232 shares or three times its daily average. THOR is a world leader in device-based mechanical circulatory support therapies to save, support and restore failing hearts.

SDIX soars, BAC busy, KV troubled

Wednesday, January 12th, 2011

Strategic Diagnostics Inc. (Nasdaq: SDIX) shares shot higher 42.5 percent Wednesday to $2.65, on volume of 2,094,668 shares, towering over its full-day average of about 31,000. SDIX announced Wednesday its RapidChek SELECT Salmonella Enteritidis (SE) test system has been reviewed by FDA and determined to be equivalent in accuracy, precision and sensitivity to their current standard methods for poultry house environmental drag swabs and pooled egg testing.

Bank of America Corp. (NYSE: BAC) traded in 113,699,846 shares noon Wednesday, nearly half its all-day average. Prices for BAC moved forward 1.8 percent to $14.95, as part of a general upward trend for bank stocks.

K-V Pharmaceutical Company (NYSE: KV.A) fell 21.9 percent Wednesday to $1.78. Volume for the stock was 1,722,746 shares or nearly five times its daily verage, after the company said it was “evaluating its liquidity outlook” in light of a delay by U.S. regulators over approval of a treatment to prevent preterm birth.